Author

C. Mullan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Assay:clinical cohort / trial· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Organism:chicken / avian· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

M. Bucholc· 2 shared M. O'Kane· 2 shared S. Ashe· 2 shared A. Filipe· 1 shared A. H. Patel· 1 shared A. Hardy· 1 shared A. Kohl· 1 shared A. Shaw· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

M. Bucholc

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Timing and magnitude of the type-I interferon response are determinants of disease tolerance in arbovirus infection

A. Hardy, S. Bakshi, W. Furnon, O. MacLean, Q. Gu, M. Varjak, M. Varela, M. A. Aziz, A. Shaw, R. M. Pinto, N. C. Ruiz, C. Mullan, A. Taggart, A. Filipe, R. E. Randall, , M. Palmarini

This study shows that the timing and magnitude of the type-I interferon response determine disease tolerance in bluetongue virus infection between sheep and cattle.

bioRxiv · Oct 19, 2022 · PreprintMicrobiology

A human and rhesus macaque interferon-stimulated gene screen reveals ARHGEF3/XPLN as an antiviral gene against hepatitis C virus and other flaviviruses

C. Bamford, E. Aranday-Cortes, R. Sanchez-Velazquez, C. Mullan, A. Kohl, A. H. Patel, S. J. Wilson, J. McLauchlan

This study identifies ARHGEF3/XPLN as an antiviral gene that inhibits HCV and flavivirus replication in both humans and rhesus macaques through a genome-wide screen.

bioRxiv · May 12, 2022 · PreprintMicrobiology

Effects of a demand optimization intervention on laboratory test utilization in primary care

M. Bucholc, M. O'Kane, B. O'Hare, C. Mullan, P. Cavanagh, S. Ashe

This study evaluates a demand optimization intervention's impact on laboratory test utilization by GPs, finding mixed effects including reduced profile tests and increased HbA1c and PSA variability.

bioRxiv · Mar 12, 2019 · PreprintPathology

Primary care use of laboratory tests in Northern Ireland Western Health and Social Care Trust: a cross-sectional study

M. Bucholc, M. O'Kane, C. Mullan, S. Ashe, L. Maguire

This study examines variations in laboratory test ordering by GPs in Northern Ireland, finding no significant association with demographic or socioeconomic factors, but noting differences related to practice setting.

bioRxiv · Mar 12, 2019Biochemistry